跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
维德思 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Valacyclovir Hydrochloride Tablets
Approved
化学药品
Valacyclovir Hydrochloride Tablets
WELLCOME FOUNDATION LIMITED(THE)
🇨🇳 National Medical Products Administration
Approval Date
Nov 9, 2018
Approval ID
7MazXbQz9ec
Company
WELLCOME FOUNDATION LIMITED(THE)
Type
化学药品
Approval Details
Approval Id
7MazXbQz9ec
Approval Number
H20150209
Generic Name
盐酸伐昔洛韦片
Generic Name En
Valacyclovir Hydrochloride Tablets
Trade Name
维德思
Brand Name
维德思
Drug Type
化学药品
Dosage Form
片剂
Strength
0.5g(按伐昔洛韦计)
Reg Date
2018-11-09
Expired Date
2023-11-08
Company Name
WELLCOME FOUNDATION LIMITED(THE)
Company Address
980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
Production Company Name
Glaxo Wellcome SA
Production Company Address
Avenida de Extremadura 3, Aranda de Duero, Burgos, E-09400, Spain
Company Detail Path
/organization/wellcome-foundation-limited-the
Production Company Detail Path
/organization/glaxo-wellcome-sa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 9, 2018
Approval ID
7MazXbQz9ec
Type
化学药品
Back to NMPA Approvals